This risk assessment details the latest epidemiological data in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) with a focus on older age groups and national reports of outbreaks among residents of LTCFs. All EU/EEA countries and the UK have experienced outbreaks among LTCF residents since August 2020.
This assessment considers the risk to human health posed by SARS-CoV-2 mink related variants. It is based on information available to ECDC at the time of publication and, unless otherwise stated, the assessment of risk refers to the risk that existed at the time of writing.
In this update, we assess the risk for the general population and vulnerable individuals in relation to the increase in COVID-19 notification rates in the EU/EEA and the UK.
In this update, we analyse the risk posed to the general population, vulnerable individuals, and healthcare provision by the current increase in COVID-19 case notification rates observed in the EU/EEA and the UK.
Cases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain Reaction (PCR) test remained positive for a long period of time following the first episode of infection or whether it represents a true reinfection.
In this update, ECDC analyses the risk of further escalation of COVID-19 in the countries that have reported a recent increase in COVID-19 cases and the risk of further escalation of COVID-19 across all EU/EEA countries and the UK.
A recently published study conducted between 2011 and 2018 in China, and based on surveillance data in pigs, identified an emerging genotype 4 (G4) reassortant Eurasian avian-like (EA) A(H1N1) swine influenza virus that contains internal genes from the human A(H1N1)pdm09 and North American triple-reassortant (TR) lineage-derived internal genes.
While decreasing trends in disease incidence are being observed in Europe overall (12% decrease in 14-day incidence of reported cases between 16 and 30 June), there is still community transmission reported in most EU/EEA countries, the UK and EU candidate and potential candidate countries. Additionally, some countries are reporting a resurgence of observed cases or large localised outbreaks.
Since 31 December 2019 and as of 9 June 2020, 7 069 278 cases of COVID-19 have been reported worldwide, including 405 587 deaths. EU/EEA countries and the UK reported 1 444 710 cases (20% of all cases), including 169 207 deaths (42% of all deaths).
Several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterised, among others, by fever, abdominal pain and cardiac involvement. A possible temporal association with SARS-COV-2 infection has been hypothesised because some of the children that were tested for SARS-CoV-2 infection were either positive by polymerase chain reaction (PCR) or serology.